GENERAL VASCULAR A
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $11,873 | 1 | 0 |
| 2020 | $99.68 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11,873 | 1 | 99.2% |
| Food and Beverage | $99.68 | 1 | 0.8% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Predicting the Risk of Vascular Access Complications in Patients with Peripheral Arterial Disease undergoing TAVR Insights from the Duke CT TAVR Registry ISRCAR00258 | Boston Scientific Corporation | $11,873 | 0 |
Top Doctors Receiving Payments for GENERAL VASCULAR A
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Durham, NC | $11,873 | 1 |
| , MD | Cardiovascular Disease | Huntington, WV | $99.68 | 1 |
Manufacturing Companies
- Boston Scientific Corporation $11,873
- BOSTON SCIENTIFIC CORPORATION $99.68
Product Information
- Type Device
- Total Payments $11,972
- Total Doctors 1
- Transactions 2
About GENERAL VASCULAR A
GENERAL VASCULAR A is a device associated with $11,972 in payments to 1 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2020 to 2021. In 2021, $11,873 was paid across 1 transactions to 0 doctors.
The most common payment nature for GENERAL VASCULAR A is "Unspecified" ($11,873, 99.2% of total).
GENERAL VASCULAR A is associated with 1 research study, including "Predicting the Risk of Vascular Access Complications in Patients with Peripheral Arterial Disease undergoing TAVR Insights from the Duke CT TAVR Registry ISRCAR00258" ($11,873).